Biological and Biomedical Science
 DMS Home  /  About DMS  /  Current Student Resources  /  Contact Us  /  Search 

Donald Coen

Department of Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Seeley G. Mudd Building, Room 304
250 Longwood Avenue
Boston, MA 02115
Tel: (617) 432-1691
Fax: (617) 432-3833
Email: don_coen@hms.harvard.edu

Web Page: The Coen Lab
6 postdoctoral fellows, 3 graduate students

Our laboratory takes molecular approaches to gene regulation and protein function during herpesvirus replication and latency. We conduct these studies to provide excellent models for biological processes in eukaryotic cells and, because herpesviruses are important pathogens, to exploit differences between herpesvirus and cellular processes for safe and effective antiviral therapy. Areas of research include:

Novel post-transcriptional regulatory mechanisms. Projects include exploring microRNAs, regulated polyadenylation, ribosomal frameshifting, internal ribosome entry sites (IRES's), and translational regulation during herpes simplex virus (HSV) infection.

Herpesvirus DNA replication proteins: antiviral drug targets and prototypes for human replication proteins. Projects include determining the 3-D structures of these proteins (with the Hogle lab) and exploring their interactions with each other and nucleic acids via biochemical, mutational, and biophysical approaches, including (with the Golan and van Oijen labs) single molecule methods. These studies should permit detailed understanding of these complicated proteins and rational drug design.

Drug targets and development of new therapies. Aside from studies of herpesvirus DNA replication proteins, projects include exploiting for drug discovery the human cytomegalovirus protein kinase that phosphorylates the nucleoside analog ganciclovir and the important cellular proteins Rb and lamin A/C investigating how it promotes replication of the virus, and finding new drug targets by a combination of "chemical genetic" and molecular genetic approaches.

HSV latency/pathogenesis. HSV forms latent infections that persist for the life of the host. How this occurs is biologically fascinating and clinically important. Projects entail mutant construction, and PCR-based and microarray methods to explore viral gene regulation (e.g. how microRNAs repress viral gene expression, thereby maintaining latency), and neuronal genes whose expression is altered during viral latency.


 

References:

  • Griffiths A, Coen DM. An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 2005; 102:9667-9772.
  • Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta, RF. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008; 320:797-799.
  • Lin Umbach J, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature; 2008; in press.
  • Komazin-Meredith G, Mirchev, R, Golan, DE, van Oijen AM, Coen DM. Hopping of a processivity factor on DNA revealed by single molecule assays of diffusion. Proc Natl Acad Sci USA; accepted for publication.